Severe recalcitrant psoriasis treated with itolizumab, a novel anti-CD6 monoclonal antibody.
Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune, Maharashtra, India.
Aayush
A
Gupta
Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune, Maharashtra, India.
Yugal Kishor
YK
Sharma
Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune, Maharashtra, India.
Kirti
K
Deo
Department of Dermatology, Dr. D.Y. Patil Medical College and Hospital, Pune, Maharashtra, India.
Preeti
P
Kothari
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000175:diagnosis* / Q000188:drug therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
D061067:Antibodies, Monoclonal, Humanized; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; C062279:CD6 antigen; C000597346:itolizumab